| Dr Stephanie Kerstin Kukora, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Dr Stephanie Kerstin Kukora |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396972857 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 4301094523 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Kerstin Kukora, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Dr Stephanie Kerstin Kukora, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
Healthcare facilities continue to battle drug-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) that loiter on surfaces even after patient rooms have been cleaned and can cause new, sometimes-deadly infections.
Firefighter deaths due to heart attacks may not be due to bad diets, but from exposure to hydrogen cyanide in fire smoke. Nationally, six firefighters have literally dropped dead from heart attacks after coming off of a shift of smoky fires and more than 100 were treated or hospitalized for smoke inhalation since January 1.
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced the New Drug Application (NDA) for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), has been accepted for review by the U.S. Food and Drug Administration.
› Verified 3 days ago
Dr. Michael Edmund Watson, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Joanna Van Beek, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, D3238 Mpb Spc 5718, Ann Arbor, MI 48109 Phone: 734-763-5589 Fax: 734-763-4208 | |
Ashleigh Grund El Sakr, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4900 Jackson Rd Ste A, Ann Arbor, MI 48103 Phone: 734-998-7380 | |
Jennifer Rose Blase, MD, PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Vishvanie Bernadene Stoody, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Maysa Hamade, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Alejandro Velez Lopez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |